Page 44 - Read Online

Marasco et al. Hepatoma Res 2020;6:32 I http://dx.doi.org/10.20517/2394-5079.2019.54 Page 13 of 17

infection. Eur J Gastroenterol Hepatol 2013;25:428-34.
27. Zhou H, Long J, Hu H, Tian CY, Lin SD. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet
Baveno VI criteria. World J Gastroenterol 2019;25:5323-33.
28. Mobarak L, Omran D, Nabeel MM, Zakaria Z. Fibro markers for prediction of hepatocellular carcinoma in Egyptian patients with chronic
liver disease. J Med Virol 2017;89:1062-8.
29. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a
simple predictive model. Hepatology 2002;36:986-92.
30. Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, et al. Validation and comparison of indexes for fibrosis and cirrhosis
prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat
2006;13:659-70.
31. Choi WM, Lee JH, Ahn H, Cho H, Cho YY, et al. Forns index predicts recurrence and death in patients with hepatitis B-related
hepatocellular carcinoma after curative resection. Liver Int 2015;35:1992-2000.
32. Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, et al. Assessment of liver function in patients with hepatocellular
carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 2015;33:550-8.
33. Wang J, Zhang Z, Yan X, Li M, Xia J, et al. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis
B-related liver cirrhosis. Dig Liver Dis 2019;51:1172-8.
34. Wan SZ, Nie Y, Zhang Y, Liu C, Zhu X. Assessing the prognostic performance of the Child-Pugh, model for end-stage liver disease, and
albumin-bilirubin scores in patients with decompensated cirrhosis: a large asian cohort from gastroenterology department. Dis Markers
2020;2020:5193028.
35. Zou D, Qi X, Zhu C, Ning Z, Hou F, et al. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal
bleeding in liver cirrhosis: a retrospective study. Turkish J Gastroenterol 2016;27:180-6.
36. Xu YX, Wang YB, Tan YL, Xi C, Xu XZ. Prognostic value of pretreatment albumin to bilirubin ratio in patients with hepatocellular
cancer: a meta-analysis. Medicine (Baltimore) 2019;98:e14027.
37. Zou H, Yang X, Li QL, Zhou QX, Xiong L, et al. A comparative study of albumin-bilirubin score with Child-Pugh score, model for end-
stage liver disease score and indocyanine green R15 in predicting posthepatectomy liver failure for hepatocellular carcinoma patients. Dig
Dis 2018;36:236-43.
38. Toyoda H, Lai PBS, O’Beirne J, Chong CC, Berhane S, et al. Long-term impact of liver function on curative therapy for hepatocellular
carcinoma: application of the ALBI grade. Br J Cancer 2016;114:744-50.
39. Wang YY, Zhong JH, Su ZY, Huang JF, Lu SD, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver
resection for hepatocellular carcinoma. Br J Surg 2016;103:725-34.
40. Ke M, Xu T, Li N, Ren Y, Shi A, et al. Prognostic nutritional index predicts short-term outcomes after liver resection for hepatocellular
carcinoma within the Milan criteria. Oncotarget 2016;7:81611-20.
41. Andreatos N, Amini N, Gani F, Margonis GA, Sasaki K, et al. Albumin-bilirubin score: predicting short-term outcomes including bile
leak and post-hepatectomy liver failure following hepatic resection. J Gastrointest Surg 2017;21:238-48.
42. Li MX, Zhao H, Bi XY, Li ZY, Huang Z, et al. Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma:
validation in a chinese cohort. Hepatol Res 2017;47:731-41.
43. Russolillo N, Forchino F, Conci S, Mele C, Langella S, et al. Validation of the albumin-indocyanine green evaluation model in patients
with resected hepatocellular carcinoma and comparison with the albumin-bilirubin score. J Hepatobiliary Pancreat Sci 2019;26:51-7.
44. Božin T, Mustapić S, Bokun T, Patrlj L, Rakić M, et al. Albi score as a predictor of survival in patients with compensated cirrhosis
resected for hepatocellular carcinoma: exploratory evaluation in relationship to palbi and meld liver function scores. Acta Clin Croat
2018;57:292-300.
45. Mai RY, Wang YY, Bai T, Chen J, Xiang BD, et al. Combination of ALBI and APRI to predict posthepatectomy liver failure after liver
resection for HBV-related HCC patients. Cancer Manag Res 2019;11:8799-806.
46. De Gasperi A, Mazza E, Prosperi M. Indocyanine green kinetics to assess liver function: ready for a clinical dynamic assessment in major
liver surgery? World J Hepatol 2016;8:355-67.
47. Levesque E, Martin E, Dudau D, Lim C, Dhonneur G, et al. Current use and perspective of indocyanine green clearance in liver diseases.
Anaesth Crit Care Pain Med 2016;35:49-57.
48. Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M, Cecinato P, et al. Indocyanine green retention test as a noninvasive marker of portal
hypertension and esophageal varices in compensated liver cirrhosis. Hepatology 2014;59:643-50.
49. Kim HJ, Kim CY, Park EK, Hur YH, Koh YS, et al. Volumetric analysis and indocyanine green retention rate at 15 min as predictors of
post-hepatectomy liver failure. HPB 2015;17:159-67.
50. Cheung TT, Chan SC, Chok KSH, Chan ACY, Yu WC, et al. Rapid measurement of indocyanine green retention by pulse
spectrophotometry: a validation study in 70 patients with Child-Pugh A cirrhosis before hepatectomy for hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int 2012;11:267-71.
51. Purcell R, Kruger P, Jones M. Indocyanine green elimination: a comparison of the LiMON and serial blood sampling methods. ANZ J
Surg 2006;76:75-7.
52. Lisotti A, Azzaroli F, Cucchetti A, Buonfiglioli F, Cecinato P, et al. Relationship between indocyanine green retention test,
decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension. Liver Int 2016;36:1313-21.
53. Zipprich A, Kuss O, Rogowski S, Kleber G, Lotterer E, et al. Incorporating indocyanin green clearance into the model for end stage liver
disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut 2010;59:963-8.